EBAG9 polyclonal antibody
* The price is valid only in USA. Please select country.
-
More Files
- More Functions
-
Specification
Product Description
Rabbit polyclonal antibody raised against synthetic peptide of EBAG9.
Immunogen
A synthetic peptide corresponding to C-terminus of human EBAG9.
Host
Rabbit
Theoretical MW (kDa)
32
Reactivity
Human
Specificity
This antibody recognizes ~32 KDa EBAG9.
Form
Liquid
Quality Control Testing
Antibody Reactive Against Synthetic Peptide.
Recommend Usage
Western Blot (0.1-1 ug/mL)
ELISA (0.01-0.1 ug/mL)
Immunoprecipitation (2-5 ug/mL)
The optimal working dilution should be determined by the end user.Storage Buffer
In TBS, pH 7.2 (BSA, 10% Proclin300)
Storage Instruction
Store at 4°C. For long term storage store at -20°C or lower.
Aliquot to avoid repeated freezing and thawing. -
Applications
Western Blot (Tissue lysate)
The tissue lysate derived from human liver tissue lysate was immunoprobed by EBAG9 polyclonal antibody (Cat # PAB12726) at 1 : 500. An immunoreactive band is observed around ~32 kDa (1). The lane 2 is a negative control.Immunohistochemistry
Immunoprecipitation
Enzyme-linked Immunoabsorbent Assay
-
Gene Info — EBAG9
Entrez GeneID
9166Gene Name
EBAG9
Gene Alias
EB9, PDAF, RCAS1
Gene Description
estrogen receptor binding site associated, antigen, 9
Omim ID
605772Gene Ontology
HyperlinkGene Summary
This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor which binds to the estrogen-responsive element (ERE) found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Two transcript variants differing in the 5' UTR, but encoding the same protein, have been identified for this gene. [provided by RefSeq
Other Designations
cancer associated surface antigen|estrogen receptor binding site associated antigen 9
-
Interactome
-
Publication Reference
-
The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma.
Fukuda K, Tsujitani S, Maeta Y, Yamaguchi K, Ikeguchi M, Kaibara N.
Gastric Cancer 2002 Jan; 5(4):220.
Application:IHC, Human, Human gastric adenocarcinoma.
-
The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma.
- +1-909-264-1399
+1-909-992-0619
Toll Free : +1-877-853-6098 - +1-909-992-3401
- sales@abnova.com